Literature DB >> 35035299

NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.

Ruth Ann Marrie1, Gary R Cutter2, Robert J Fox3, Timothy Vollmer4, Tuula Tyry5, Amber Salter6.   

Abstract

Observational studies and registries can play a critical role in elucidating the natural and treated history of multiple sclerosis (MS) and identifying factors associated with outcomes such as disability and health-related quality of life. The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is one of multiple registries worldwide that focuses on people with MS, but one of the very few patient-driven MS registries. On the 25th anniversary of the first data collection for the NARCOMS Registry, we discuss the importance of disease registries in the MS field, describe key concepts related to registry design and management, and highlight findings from MS registries relevant to clinical care or health policy.
© 2021 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Epidemiology; Multiple sclerosis (MS); NARCOMS; Registry

Year:  2021        PMID: 35035299      PMCID: PMC8745235          DOI: 10.7224/1537-2073.2020-133

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  45 in total

1.  Does multiple sclerosis-associated disability differ between races?

Authors:  R A Marrie; G Cutter; T Tyry; T Vollmer; D Campagnolo
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Data quality evaluation for observational multiple sclerosis registries.

Authors:  Tomas Kalincik; Jens Kuhle; Eugenio Pucci; Juan Ignacio Rojas; Magda Tsolaki; Carmen-Adella Sirbu; Mark Slee; Helmut Butzkueven
Journal:  Mult Scler       Date:  2016-08-05       Impact factor: 6.312

Review 3.  Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures.

Authors:  V Khurana; H Sharma; N Afroz; A Callan; J Medin
Journal:  Eur J Neurol       Date:  2017-07-11       Impact factor: 6.089

4.  Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

Authors:  Kyla A McKay; Helen Tremlett; John D Fisk; Tingting Zhang; Scott B Patten; Lorne Kastrukoff; Trudy Campbell; Ruth Ann Marrie
Journal:  Neurology       Date:  2018-03-09       Impact factor: 9.910

5.  Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Authors:  Mathias Granqvist; Joachim Burman; Martin Gunnarsson; Jan Lycke; Petra Nilsson; Tomas Olsson; Peter Sundström; Anders Svenningsson; Magnus Vrethem; Thomas Frisell; Fredrik Piehl
Journal:  Mult Scler       Date:  2019-08-08       Impact factor: 6.312

6.  Diet quality is associated with disability and symptom severity in multiple sclerosis.

Authors:  Kathryn C Fitzgerald; Tuula Tyry; Amber Salter; Stacey S Cofield; Gary Cutter; Robert Fox; Ruth Ann Marrie
Journal:  Neurology       Date:  2017-12-06       Impact factor: 9.910

7.  Validation of the NARCOMS registry: diagnosis.

Authors:  R A Marrie; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Mult Scler       Date:  2007-03-15       Impact factor: 6.312

8.  Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.

Authors:  Robert W Motl; Jeffrey A Cohen; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

9.  Maelstrom Research guidelines for rigorous retrospective data harmonization.

Authors:  Isabel Fortier; Parminder Raina; Edwin R Van den Heuvel; Lauren E Griffith; Camille Craig; Matilda Saliba; Dany Doiron; Ronald P Stolk; Bartha M Knoppers; Vincent Ferretti; Peter Granda; Paul Burton
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

10.  Landscape of MS patient cohorts and registries: Recommendations for maximizing impact.

Authors:  Bruce F Bebo; Robert J Fox; Karen Lee; Ursula Utz; Alan J Thompson
Journal:  Mult Scler       Date:  2017-03-01       Impact factor: 6.312

View more
  2 in total

1.  Disparities in Telehealth Care in Multiple Sclerosis.

Authors:  Ruth Ann Marrie; Leanne Kosowan; Gary Cutter; Robert Fox; Amber Salter
Journal:  Neurol Clin Pract       Date:  2022-06

2.  Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis.

Authors:  Ruth Ann Marrie; Casandra Dolovich; Gary R Cutter; Robert J Fox; Amber Salter
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.